FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009456868> ?p ?o ?g. }

• W2009456868 endingPage "4182" @default.
• W2009456868 startingPage "4173" @default.
• W2009456868 abstract "Preclinical investigations and early clinical trial studies suggest that FLT3 inhibitors offer a viable therapy for acute myeloid leukemia. However, early clinical data for direct FLT3 inhibitors provided only modest results because of the failure to fully inhibit FLT3. We have designed and synthesized a novel class of 3-phenyl-1H-5-pyrazolylamine-derived compounds as FLT3 inhibitors which exhibit potent FLT3 inhibition and high selectivity toward different receptor tyrosine kinases. The structure-activity relationships led to the discovery of two series of FLT3 inhibitors, and some potent compounds within these two series exhibited comparable potency to FLT3 inhibitors sorafenib (3) and ABT-869 (4) in both wt-FLT3 enzyme inhibition and FLT3-ITD inhibition on cell growth (MOLM-13 and MV4;11 cells). In particular, the selected compound 12a exhibited the ability to regress tumors in mouse xenograft models using MOLM-13 and MV4;11 cells." @default.
• W2009456868 created "2016-06-24" @default.
• W2009456868 creator A5002576867 @default.
• W2009456868 creator A5010143448 @default.
• W2009456868 creator A5031575332 @default.
• W2009456868 creator A5033220954 @default.
• W2009456868 creator A5036592907 @default.
• W2009456868 creator A5037271959 @default.
• W2009456868 creator A5050488521 @default.
• W2009456868 creator A5050522883 @default.
• W2009456868 creator A5054217593 @default.
• W2009456868 creator A5058918636 @default.
• W2009456868 creator A5061434695 @default.
• W2009456868 creator A5068878368 @default.
• W2009456868 creator A5069278687 @default.
• W2009456868 creator A5071634459 @default.
• W2009456868 creator A5076915406 @default.
• W2009456868 creator A5082482214 @default.
• W2009456868 creator A5088119125 @default.
• W2009456868 creator A5088705788 @default.
• W2009456868 date "2011-07-01" @default.
• W2009456868 modified "2023-09-27" @default.
• W2009456868 title "Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)" @default.
• W2009456868 cites W1542395305 @default.
• W2009456868 cites W1557061959 @default.
• W2009456868 cites W1627121503 @default.
• W2009456868 cites W1971028883 @default.
• W2009456868 cites W1975386736 @default.
• W2009456868 cites W1984965777 @default.
• W2009456868 cites W1988614680 @default.
• W2009456868 cites W1990030298 @default.
• W2009456868 cites W1990793563 @default.
• W2009456868 cites W2003973314 @default.
• W2009456868 cites W2010898909 @default.
• W2009456868 cites W2011187792 @default.
• W2009456868 cites W2035355148 @default.
• W2009456868 cites W2044942890 @default.
• W2009456868 cites W2050537958 @default.
• W2009456868 cites W2057335049 @default.
• W2009456868 cites W2063512315 @default.
• W2009456868 cites W2126506327 @default.
• W2009456868 cites W2151222524 @default.
• W2009456868 cites W2163515240 @default.
• W2009456868 doi "https://doi.org/10.1016/j.bmc.2011.06.016" @default.
• W2009456868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21708468" @default.
• W2009456868 hasPublicationYear "2011" @default.
• W2009456868 type Work @default.
• W2009456868 sameAs 2009456868 @default.
• W2009456868 citedByCount "15" @default.
• W2009456868 countsByYear W20094568682012 @default.
• W2009456868 countsByYear W20094568682013 @default.
• W2009456868 countsByYear W20094568682014 @default.
• W2009456868 countsByYear W20094568682015 @default.
• W2009456868 countsByYear W20094568682016 @default.
• W2009456868 countsByYear W20094568682017 @default.
• W2009456868 countsByYear W20094568682019 @default.
• W2009456868 countsByYear W20094568682020 @default.
• W2009456868 crossrefType "journal-article" @default.
• W2009456868 hasAuthorship W2009456868A5002576867 @default.
• W2009456868 hasAuthorship W2009456868A5010143448 @default.
• W2009456868 hasAuthorship W2009456868A5031575332 @default.
• W2009456868 hasAuthorship W2009456868A5033220954 @default.
• W2009456868 hasAuthorship W2009456868A5036592907 @default.
• W2009456868 hasAuthorship W2009456868A5037271959 @default.
• W2009456868 hasAuthorship W2009456868A5050488521 @default.
• W2009456868 hasAuthorship W2009456868A5050522883 @default.
• W2009456868 hasAuthorship W2009456868A5054217593 @default.
• W2009456868 hasAuthorship W2009456868A5058918636 @default.
• W2009456868 hasAuthorship W2009456868A5061434695 @default.
• W2009456868 hasAuthorship W2009456868A5068878368 @default.
• W2009456868 hasAuthorship W2009456868A5069278687 @default.
• W2009456868 hasAuthorship W2009456868A5071634459 @default.
• W2009456868 hasAuthorship W2009456868A5076915406 @default.
• W2009456868 hasAuthorship W2009456868A5082482214 @default.
• W2009456868 hasAuthorship W2009456868A5088119125 @default.
• W2009456868 hasAuthorship W2009456868A5088705788 @default.
• W2009456868 hasConcept C101544691 @default.
• W2009456868 hasConcept C104317684 @default.
• W2009456868 hasConcept C126322002 @default.
• W2009456868 hasConcept C170493617 @default.
• W2009456868 hasConcept C181199279 @default.
• W2009456868 hasConcept C184235292 @default.
• W2009456868 hasConcept C185592680 @default.
• W2009456868 hasConcept C193042331 @default.
• W2009456868 hasConcept C202751555 @default.
• W2009456868 hasConcept C2776980637 @default.
• W2009456868 hasConcept C2778019345 @default.
• W2009456868 hasConcept C2778461978 @default.
• W2009456868 hasConcept C2778695046 @default.
• W2009456868 hasConcept C2778729363 @default.
• W2009456868 hasConcept C2910954276 @default.
• W2009456868 hasConcept C42362537 @default.
• W2009456868 hasConcept C501734568 @default.
• W2009456868 hasConcept C502942594 @default.
• W2009456868 hasConcept C55493867 @default.
• W2009456868 hasConcept C57992300 @default.
• W2009456868 hasConcept C71924100 @default.
• W2009456868 hasConcept C86803240 @default.

• next